Food and Drug Administration Tobacco Regulation and Product Judgments

Published:February 24, 2015DOI:


      The Family Smoking Prevention and Tobacco Control Act granted the Food and Drug Administration (FDA) the authority to regulate tobacco products in the U.S. However, little is known about how regulation may be related to judgments about tobacco product–related risks.


      To understand how FDA tobacco regulation beliefs are associated with judgments about tobacco product–related risks.


      The Health Information National Trends Survey is a national survey of the U.S. adult population. Data used in this analysis were collected from October 2012 through January 2013 (N=3,630) by mailed questionnaire and analyzed in 2013. Weighted bivariate chi-square analyses were used to assess associations among FDA regulation belief, tobacco harm judgments, sociodemographics, and smoking status. A weighted multinomial logistic regression was conducted where FDA regulation belief was regressed on tobacco product judgments, controlling for sociodemographic variables and smoking status.


      About 41% believed that the FDA regulates tobacco products in the U.S., 23.6% reported the FDA does not, and 35.3% did not know. Chi-square analyses showed that smoking status was significantly related to harm judgments about electronic cigarettes (p<0.0001). The multinomial logistic regression revealed that uncertainty about FDA regulation was associated with tobacco product harm judgment uncertainty.


      Tobacco product harm perceptions are associated with beliefs about tobacco product regulation by the FDA. These findings suggest the need for increased public awareness and understanding of the role of tobacco product regulation in protecting public health.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Preventive Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


      1. Family Smoking Prevention and Tobacco Control Act. 2009; Pub. L. 111-31.

        • Weinstein N.D.
        • Slovic P.
        • Gibson G.
        Accuracy and optimism in smokers’ beliefs about quitting.
        Nicotine Tob Res. 2004; 6 ( S375-S380
        • Weinstein N.D.
        Accuracy of smokers’ risk perceptions.
        Ann Behav Med. 1998; 20 ( 135-140
        • Weinstein N.D.
        • Slovic P.
        • Waters E.
        • Gibson G.
        Public understanding of the illnesses caused by cigarette smoking.
        Nicotine Tob Res. 2004; 6 ( 349-355
        • Weinstein N.D.
        • Marcus S.E.
        • Moser R.P.
        Smokers’ unrealistic optimism about their risk.
        Tob Control. 2005; 14 ( 55-59
        • Pederson L.L.
        • Nelson D.E.
        Literature review and summary of perceptions, attitudes, beliefs, and marketing of potentially reduced exposure products: Communication implications.
        Nicotine Tob Res. 2007; 9 ( 525-534
        • Hughes J.R.
        • Keely J.P.
        • Callas P.W.
        Ever users versus never users of a “less risky" cigarette.
        Psychol Addict Behav. 2005; 19 ( 439
        • O’Connor R.J.
        • Hyland A.
        • Giovino G.A.
        • Fong G.T.
        • Cummings K.M.
        Smoker awareness of and beliefs about supposedly less-harmful tobacco products.
        Am J Prev Med. 2005; 29 ( 85-90
        • Parascandola M.
        • Hurd A.L.
        • Augustson E.
        Consumer awareness and attitudes related to new potential reduced-exposure tobacco products.
        Am J Health Behav. 2008; 32 ( 431-437
        • O’Hegarty M.
        • Richter P.
        • Pederson L.L.
        What do adult smokers think about ads and promotional materials for PREPs?.
        Am J Health Behav. 2007; 31 ( 526-534
        • Kaufman A.R.
        • Waters E.A.
        • Parascandola M.
        • et al.
        Food and Drug Administration evaluation and cigarette smoking risk perceptions.
        Am J Health Behav. 2011; 35 ( 766-776
        • Nelson D.
        • Kreps G.
        • Hesse B.
        • et al.
        The Health Information National Trends Survey (HINTS): development, design, and dissemination.
        J Health Commun. 2004; 9 ( 443-460
      2. Westat. Health Information National Trends Survey 4 (HINTS 4): cycle 2. Rockville, MD: Westat; 2013.

        • Pearson J.L.
        • Richardson A.
        • Niaura R.S.
        • Vallone D.M.
        • Abrams D.B.
        E-cigarette awareness, use, and harm perceptions in U.S. adults.
        Am J Public Health. 2012; 102 ( 1758-1766
        • Parascandola M.
        • Augustson E.
        • O’Connell M.E.
        • Marcus S.
        Consumer awareness and attitudes related to new potential reduced-exposure tobacco product brands.
        Nicotine Tob Res. 2009; 11 ( 886-895
        • Waters E.A.
        • Hay J.L.
        • Orom H.
        • Kiviniemi M.T.
        • Drake B.F.
        “Don’t Know” responses to risk perception measures implications for underserved populations.
        Med Decis Making. 2013; 33 ( 271-281